↓ Skip to main content

Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review

Overview of attention for article published in Drug Safety, December 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
13 X users
facebook
1 Facebook page

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
97 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review
Published in
Drug Safety, December 2015
DOI 10.1007/s40264-015-0370-0
Pubmed ID
Authors

Thi-Ha Vo, Bruno Charpiat, Claire Catoire, Michel Juste, Renaud Roubille, François-Xavier Rose, Sébastien Chanoine, Jean-Luc Bosson, Ornella Conort, Benoît Allenet, Pierrick Bedouch, On Behalf of the Working Group “Standardizing and Demonstrating the Value of Clinical Pharmacy Activities” of the French Society for Clinical Pharmacy

Abstract

Assessing the significance of pharmacist interventions (PIs) is essential to demonstrate the added value of pharmacists. Methods and tools for assessing the potential significance of PIs are diverse and their properties are questionable. We aimed to systematically review the tools available to assess the potential significance of PIs. We conducted a systematic search for English- or French-language publications from 1986 to 2013 in PubMed, PsycINFO, PASCAL, and CINAHL. Studies were screened by two independent reviewers based on inclusion/exclusion criteria and were abstracted for content, structure of tools, and validation process. Of 873 citations screened, 82 distinct tools were identified from 133 studies. While clinical aspects were often defined quite clearly, terminology regarding humanistic, economic, and process-related aspects of PIs was omitted, incomplete, or ambiguous in most tools. The probabilities of consequences of PIs/drug-related problems were evaluated in 20/82 tools. Few tools simultaneously measured economic, clinical, humanistic, and process-related variables. Structure of the tools varied from an implicit, mono-dimensional tool to an explicit, multi-dimensional algorithm. Validation processes were diverse in terms of quantification and number of raters, rating method, and psychometric parameters. Of 133 identified studies, there was limited evidence of validity (8/133, 6.0 %), inter-rater reliability (49/133, 36.8 %), and intra-rater reliability (2/133, 1.5 %). The majority of tools focused primarily on assessing clinical aspects and failed to detect comprehensive impacts. The heterogeneity of tools and assessment processes hindered our ability to synthesize the results of evaluations. Limited results for their validity and reliability cast doubt on the credibility of this methodology for justification of the value of PIs. Recommendations for development of tools with optimal theoretical, pragmatic, and psychometric properties are proposed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
France 1 1%
Unknown 94 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 15%
Student > Ph. D. Student 13 13%
Researcher 10 10%
Student > Doctoral Student 9 9%
Other 5 5%
Other 12 12%
Unknown 33 34%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 27 28%
Medicine and Dentistry 16 16%
Nursing and Health Professions 5 5%
Agricultural and Biological Sciences 3 3%
Linguistics 1 1%
Other 8 8%
Unknown 37 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2018.
All research outputs
#4,499,395
of 24,153,435 outputs
Outputs from Drug Safety
#468
of 1,755 outputs
Outputs of similar age
#71,926
of 397,554 outputs
Outputs of similar age from Drug Safety
#11
of 27 outputs
Altmetric has tracked 24,153,435 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,755 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 397,554 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.